FDA approves Trelegy Ellipta for use in COPD Vinay Singh singh26 April 2018 7:25 PM ISTUS Food and Drug Administration (FDA) has approved an expanded indication for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol...
COPD: LABA/LAMA dual bronchodilation improves Cardiac function Vinay Singh singh12 May 2018 7:10 PM ISTDual bronchodilation with LABA/LAMA Combo of indacaterol-glycopyrronium is associated with significant improvement of cardiac function in patients...
Dimethyl Fumarate beneficial for CPAP-intolerant Sleep Apnea patients Vinay Singh singh23 Aug 2018 7:18 PM ISTA new study published in the journal Sleep reports that the immunomodulatory drug dimethyl fumarate (DMF) partially ameliorates obstructive sleep...
Testosterone replacement therapy slows progression of COPD Vinay Singh singh14 Sept 2018 7:25 PM ISTA new study published in the journal Chronic Respiratory Disease has found that testosterone replacement therapy may slow disease progression of the...
Slow-Release morphine safe for some obstructive sleep apnea patients Medha Baranwal Baranwal16 Sept 2018 7:10 PM ISTA new study finds that a 40-mg dose of slow-release morphine may be safe for non-severely obese patients with obstructive sleep apnea (OSA). This is...
Simplifying Endoscopic Ultrasound-Guided Biliary Drainage: The Way Forward? Vinay Singh singh19 Sept 2018 7:02 PM ISTEUS-guided choledochoduodenostomy(EUS-CD) using a lumen-apposing metal stent (LAMS) has been recently reported as an alternative treatment approach...
Weight Management Guideline in sleep apnea by American Thoracic Society Dr. Kamal Kant Kohli Kohli18 Sept 2018 7:03 PM ISTAmerican Thoracic Society has released its new guideline focused on the role of weight management in treating adult obstructive sleep apnea (OSA). The...
Ultrasound within 1 hour of ICU admission confirms type of shock Vinay Singh singh20 Sept 2018 8:28 PM ISTUltrasound carried out within 1 hour of admission to the ICU plays a major role in the correct diagnosis of the type of shock and subsequent patient...
Revefenacin has acceptable cardiovascular safety in COPD Vinay Singh singh21 Oct 2018 7:05 PM ISTRevefenacin, a once-daily lung selective muscarinic receptor antagonist for nebulization does not prolong QT interval and offers an acceptable 52...
Prophylactic antibiotics prevent COPD exacerbations,finds systematic review Vinay Singh singh2 Nov 2018 7:25 PM ISTUse of continuous and intermittent prophylactic antibiotics results in a clinically significant benefit in reducing exacerbations in COPD patients,...
FDA approves once-daily, inhalation solution for COPD Vinay Singh singh13 Nov 2018 7:28 PM ISTThe U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for YUPELRI (revefenacin) inhalation solution for the...
Triple therapy lowers exacerbation rate in COPD : BMJ Vinay Singh singh18 Nov 2018 7:28 PM ISTA new study published in the journal The BMJ reports that the use of triple therapy resulted in a lower rate of moderate or severe exacerbations of...
